King's College London

Research portal

Neuro-Oncology Practice, 2054-2577

Journal

  1. Jung, J., Tailor, J., Dalton, E., Glancz, L. J., Roach, J., Zakaria, R., Lammy, S., Chari, A., Budohoski, K. P., Livermore, L. J., Yu, K., Jenkinson, M. D., Brennan, P. M., Brazil, L., Bunce, C. V., Bourmpaki, E., Ashkan, K., & Vergani, F. (2019). Management evaluation of metastasis in the brain (MEMBRAIN)—a United Kingdom and Ireland prospective, multicenter observational study. Neuro-Oncology Practice. https://doi.org/10.1093/nop/npz063
  2. Ma, R., Chari, A., Brennan, P. M., Alalade, A., Anderson, I., Solth, A., Marcus, H. J., Watts, C., British Neurosurgical Trainee Research Collaborative, Kolias, A., Sinha, R., O'Neill, K., Rasul, F., Ashkan, K., Paine, H., Corns, R., Jenkinson, M., Kitchen, N., Holliman, D., ... Brydon, H. (2018). Residual enhancing disease after surgery for glioblastoma: Evaluation of practice in the United Kingdom. Neuro-Oncology Practice, 5(2), 74-81. https://doi.org/10.1093/nop/npx023
  3. Morris, K. A., Golding, J. F., Axon, P. R., Afridi, S., Blesing, C., Ferner, R. E., Halliday, D., Jena, R., Pretorius, P. M., Gareth Evans, D., McCabe, M. G., & Parry, A. (2016). Bevacizumab in Neurofibromatosis type 2 (NF2) related vestibular schwannomas: A nationally coordinated approach to delivery and prospective evaluation. Neuro-Oncology Practice, 3(4), 281-289. https://doi.org/10.1093/nop/npv065

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454